Human Longevity, Inc. Hires Cynthia Collins, Healthcare Industry Leader, as New Chief Executive Officer

Craig Venter, Ph.D., Co-founder and former CEO, will remain at Company as Executive Chairman and continue in full time role guiding scientific vision and strategy

(SAN DIEGO, CA)—January 4, 2017—Human Longevity, Inc. (HLI), the genomics-driven, health intelligence company, today announced Cynthia Collins as the new Chief Executive Officer effective January 9, 2017. Collins, who has a successful track record and extensive leadership experience in the life sciences sector, will lead HLI and be responsible for all functions of the company including commercialization of HLI key products and strategic operations. She will also join the Board of Directors.

Continue Reading →

Human Longevity, Inc. Announces 10 Year Deal with AstraZeneca to Sequence and Analyze Patient Samples from AstraZeneca Clinical Trials

(SAN DIEGO, CA)—April 21, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today a 10 year deal with AstraZeneca to sequence and analyze up to 500,000 DNA samples from AstraZeneca clinical trials. The genomic insights from the collaboration will be added to the HLI Knowledgebase™, building upon what is already the most comprehensive database of its kind. The deal was announced today at a press conference with AstraZeneca in Cambridge, UK. Financial terms of the deal were not disclosed.

Continue Reading →

StartUp Health Launches ‘Longevity Moonshot’ and Invests in Human Longevity, Inc. to Change Face of Aging

New York, NY (PRWEB)April 13, 2016 — StartUp Health, a global organization leading the movement to transform health by building the world’s largest community of Healthcare Transformers, today announced the launch of StartUp Health’s Longevity Moonshot, a mission to extend and enhance healthy life by 50+ years and change the face of aging. Marked by StartUp Health’s recent investment in Human Longevity, Inc (HLI), the genomics-based, technology-driven company led by co-founder and CEO J. Craig Venter, PhD., HLI was selected to be the founding partner of the Longevity Moonshot and become the 140th company to join StartUp Health’s exclusive Academy for Healthcare Transformers.

Continue Reading →

Human Longevity, Inc. Wins 2016 Bio-IT World Best Practice Award for the HLI Knowledgebase

Judges Honor Comprehensive Genome and Phenotype Database Curated with Proprietary Computational Tools by the Leading Experts in the Field

(SAN DIEGO, CA)—April 6, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, has won the 2016 Bio-IT World Best Practice Award for its HLI Knowledgebase™, a key tool in the company’s portfolio to transform how medicine is practiced.

Continue Reading →

Human Longevity, Inc. Announces Promotions and Additions to Leadership Team

Kenneth Bloom, M.D. is President and Ashley Van Zeeland, Ph.D. is Chief Technology Officer, Insurance Industry Leader Tom Wamberg Hired to Head Insurance and Corporate Sales Group

(SAN DIEGO, CA)—April 6, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today several key promotions and additions to the company’s senior leadership team.

Continue Reading →

Human Longevity, Inc. (HLI) Hires Key Oncology Leader, Kenneth J. Bloom, M.D., to Head Oncology and Immunotherapy Program

Stephen P. Schoenberger, Ph.D., to head cancer vaccine program and Ezra Cohen, M.D. is staff oncologist

(SAN DIEGO, CA)—February 3, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today the appointment of several key people for its oncology genomics program. Kenneth J. Bloom, M.D. will join the company as the new head of oncology and immunotherapy; Stephen P. Schoenberger, Ph.D. will lead cancer vaccine efforts and Ezra Cohen, M.D., who is also Associate Director and Professor of Medicine, Moores Cancer Center, University of California, San Diego, will be a staff oncologist.

Continue Reading →

Human Longevity Inc. Advances Leadership Role in Newborn Genome Sequencing with Strategic Acquisition of Stem Cell Banking from Celgene Cellular Therapeutics

HLI to Offer Newborn Genome Sequencing Product in Combination with Stem Cell Banking

(SAN DIEGO, CA)—January 28, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has agreed to purchase LifebankUSA, a leader in placental and cord blood banking, along with its proprietary and high-yield method for extracting placental stem cells and related therapeutic programs, and the biomaterials program which includes the marketed product Biovance®, a cell matrix critical to wound healing applications.

Continue Reading →

Page 1 of 4 1234